Cuu Long Pharmaceutical Bilan de santé
Santé financière contrôle des critères 5/6
Cuu Long Pharmaceutical has a total shareholder equity of ₫1,483.9B and total debt of ₫750.6B, which brings its debt-to-equity ratio to 50.6%. Its total assets and total liabilities are ₫2,396.5B and ₫912.7B respectively. Cuu Long Pharmaceutical's EBIT is ₫72.2B making its interest coverage ratio 3.9. It has cash and short-term investments of ₫226.9B.
Informations clés
50.6%
Ratio d'endettement
₫750.60b
Dette
| Ratio de couverture des intérêts | 3.9x |
| Argent liquide | ₫226.89b |
| Fonds propres | ₫1.48t |
| Total du passif | ₫912.68b |
| Total des actifs | ₫2.40t |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: DCL's short term assets (₫1,428.6B) exceed its short term liabilities (₫630.4B).
Passif à long terme: DCL's short term assets (₫1,428.6B) exceed its long term liabilities (₫282.3B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: DCL's net debt to equity ratio (35.3%) is considered satisfactory.
Réduire la dette: DCL's debt to equity ratio has reduced from 95.2% to 50.6% over the past 5 years.
Couverture de la dette: DCL's operating cash flow is negative, therefore debt is not well covered.
Couverture des intérêts: DCL's interest payments on its debt are well covered by EBIT (3.9x coverage).